Minireviews
Copyright ©The Author(s) 2023.
World J Diabetes. Nov 15, 2023; 14(11): 1621-1631
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1621
Table 1 Transcription factors and long noncoding RNAs in insulin resistance
Factors related to the development of IR
Names of lncRNAs
Targeted nuclear proteins
Lipogenic activityH19, MALAT1, MEG3, and MIAT↑SREBP-1c, PPARγ, and FoxO1
GluconeogenesisMEG3 and H19↑CRTC2/CREB, FoxO1, HNF4A and ATF4
Inflammation and oxidative stressMALAT1 and H19↑EZH2 and PRC2
Cellular dysfunctionMEG3, MALAT1 and MIAT↑N/A
Table 2 Circulating microRNA in obesity
Tissue or organs
Names of miRNAs
Targeted genes
Adipocytic tissuemiR-155, miR-27a, and miR-34aSOCS1, PPAR
LivermiR-99b and miR-155FGF21, PPAR
MusclemiR-27a, miR-155, and miR-130bPPAR, PGC1α
PancreasmiR-132 and miR-92aBTG2, PTBP1
Cardiovascular systemmiR-29a, miR-410-5p, and miR-194SMAD7
Table 3 The profiles of shared long noncoding RNAs in obesity and diabetes mellitus
lncRNA
Description
Expression in obesity
Expression in DM
SRASteroid receptor RNA activatorHighLow in patients with type II diabetic cardiovascular disease[74]
ASMER-1Adipocyte-associated metabolic related lncRNA 1High in ScATHigh expression related to IR[20]
ASMER-2Adipocyte-associated metabolic related lncRNA 2High in ScATHigh expression related to IR[20]
ADNCRAdipocyte differentiation-associated lncRNALowLow[23]
HOTAIRHOX antisense intergenic RNAHighHigh[71]
Blnc1Brown fat lncRNA 1High in high-fat-diet-fed mice[28]High in the blood of patients with diabetic nephropathy[82]
H19LncRNA H19Low in obesity-associated inflammatory conditions[83]Low[84]
MALAT1Metastasis-associated lung adenocarcinoma transcript 1High[85]High expression in PBMCs from type 2 diabetes patients[39]